10.01.2008 18:30:00
|
Industry-Leading Piper Jaffray Health Care Investment Banking Team Adds Michael Brinkman
MINNEAPOLIS, Jan. 10 /PRNewswire-FirstCall/ -- Piper Jaffray today announced Michael Brinkman has joined the investment banking team to expand its health care practice on the West Coast. He will be based in the Palo Alto office and joins a team that has helped Piper Jaffray become one of the most active underwriters for growth companies in the health care industry globally*.
Brinkman joins Piper Jaffray as a managing director in the health care group, focusing on biopharmaceutical companies. He has extensive experience in public and private financings, and in advising companies on mergers and acquisitions. Previously, he was a managing director and head of biotechnology investment banking at CIBC World Markets.
"Michael is an extremely talented banker who brings extensive experience as a lead advisor in the biopharmaceutical sector," said Jon Salveson, head of investment banking at Piper Jaffray. "For 25 years, we have been steady and committed to the business of health care. Adding an energized and seasoned professional like Michael to our leading health care platform is an extension of that long-term commitment of Piper Jaffray -- a commitment which our clients have come to expect."
Brinkman earned a bachelor's degree from the University of Witwatersrand in South Africa and completed his fellowship at the Faculty of Actuaries in Edinburgh, Scotland.
*Source: Dealogic and Piper Jaffray ECM; includes deals greater than $20 million in deal size
About Piper Jaffray
Piper Jaffray Companies is a leading, international middle-market investment bank and institutional securities firm, serving the needs of middle-market corporations, private equity groups, public entities, nonprofit clients and institutional investors. Founded in 1895, Piper Jaffray provides a comprehensive set of products and services, including equity and debt capital markets products; public finance services; mergers and acquisitions advisory services; high-yield and structured products; institutional equity and fixed-income sales and trading; and equity and high-yield research. With headquarters in Minneapolis, Piper Jaffray has 25 offices across the United States and international locations in London, Hong Kong, Shanghai and Beijing. Piper Jaffray & Co. is the firm's principal operating subsidiary. (http://www.piperjaffray.com/)
Since 1895. Member SIPC and FINRA.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Piper Jaffray Companiesmehr Nachrichten
24.10.24 |
Ausblick: Piper Jaffray Companies öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
01.08.24 |
Ausblick: Piper Jaffray Companies präsentiert Quartalsergebnisse (finanzen.net) |
Analysen zu Piper Jaffray Companiesmehr Analysen
Aktien in diesem Artikel
Piper Jaffray Companies | 324,00 | 0,00% |
Indizes in diesem Artikel
S&P 600 SmallCap | 935,46 | -0,94% |